Pacira BioSciences (PCRX) Insider Trading & Ownership → How this is some devastating news (From WealthPress) (Ad) Free PCRX Stock Alerts $30.82 -0.69 (-2.19%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Pacira BioSciences (NASDAQ:PCRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$4.40 M PCRX Insider Buying and Selling by Quarter Ad Awesomely, LLCAutomatic Income (from home)Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…Watch this short video Pacira BioSciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/8/2024Gary W PaceDirectorSell90,000$30.60$2,754,000.00 3/6/2024Gary W PaceDirectorSell1,066$29.67$31,628.22 8/2/2023Roy WinstonInsiderSell509$34.88$17,753.92 7/5/2023Lauren Bullaro RikerSVPSell643$38.91$25,019.13 6/14/2023Kristen Marie WilliamsInsiderSell6,467$37.03$239,473.01 6/14/2023Lauren Bullaro RikerSVPSell6,366$38.42$244,581.72 The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now.6/8/2023Mark A KronenfeldDirectorSell15,000$37.04$555,600.00 6/7/2023Daryl GauglerCOOSell1,047$37.87$39,649.89 6/6/2023Charles A Reinhart IIICFOSell1,236$38.99$48,191.64 6/6/2023David M StackCEOSell5,058$38.99$197,211.42 6/6/2023Lauren Bullaro RikerSVPSell591$38.99$23,043.09 6/6/2023Roy WinstonInsiderSell1,779$38.99$69,363.21 6/5/2023Daryl GauglerCOOSell1,000$38.74$38,740.00 6/5/2023Paul J HastingsDirectorSell580$38.34$22,237.20 5/31/2023Daryl GauglerCOOSell2,500$39.08$97,700.00 (Data available from 1/1/2013 forward) PCRX Insider Trading Activity - Frequently Asked Questions Who is on Pacira BioSciences's Insider Roster? The list of insiders at Pacira BioSciences includes Anthony Molloy, Charles A Reinhart III, Charles Anthony Laranjeira, Daryl Gaugler, David M Stack, Donald C Manning, Gary W Pace, John P Phd Longenecker, Jonathan Slonin, Kristen Marie Williams, Lauren Bullaro Riker, Mark A Kronenfeld, Mark Froimson, Max Reinhardt, Paul J Hastings, and Roy Winston. Learn more on insiders at PCRX. What percentage of Pacira BioSciences stock is owned by insiders? 6.40% of Pacira BioSciences stock is owned by insiders. Learn more on PCRX's insider holdings. Which Pacira BioSciences insiders have been selling company stock? The following insiders have sold PCRX shares in the last 24 months: Anthony Molloy ($20,917.26), Charles A Reinhart III ($202,598.56), Charles Anthony Laranjeira ($295,331.34), Daryl Gaugler ($243,965.11), David M Stack ($1,759,109.27), Gary W Pace ($2,995,154.92), Jonathan Slonin ($52,843.56), Kristen Marie Williams ($239,473.01), Lauren Bullaro Riker ($363,219.44), Mark A Kronenfeld ($555,600.00), Max Reinhardt ($80,040.00), Paul J Hastings ($52,591.55), and Roy Winston ($1,190,779.27). How much insider selling is happening at Pacira BioSciences? Insiders have sold a total of 195,764 Pacira BioSciences shares in the last 24 months for a total of $8,051,623.29 sold. More Insider Trading Tools from MarketBeat Related Companies: Supernus Pharmaceuticals Insider Trading Agios Pharmaceuticals Insider Trading ADC Therapeutics Insider Trading Atea Pharmaceuticals Insider Trading Nektar Therapeutics Insider Trading Seres Therapeutics Insider Trading Corcept Therapeutics Insider Trading Alkermes Insider Trading Perrigo Insider Trading Mirum Pharmaceuticals Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:PCRX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist My Default Watchlist Adding Pacira BioSciences, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
